A primer on antibodies and their role in HIV prevention research. Read on for a glossary of relevant terms and to learn how broadly neutralizing antibodies may be important to the development of a vaccine.
AIDS Vaccine Science for Busy Advocates: Antibody Research
Six Things to Know About PrEP
Six things to know about PrEP. For more information on PrEP, visit PrEPWatch.
Intervention Update: Hormonal Contraception and HIV
Excerpted from AVAC Report: HIV Prevention on the Line, this update describes recent discussion and analysis in the search for answers as to whether hormonal contraceptives, including long-acting methods such as Depo-Provera (DPMA) and other injectable contraceptives and the implant, affect women’s risk of acquiring HIV.
Intervention Update: Voluntary Medical Male Circumcision
Excerpted from AVAC Report: HIV Prevention on the Line, this update cites the success of a previous VMMC target and suggests the current lack of a target moving forward will stifle continued progress.
Intervention Update: What’s Next for AIDS Vaccines and the P5 Partnership?
Excerpted from AVAC Report: HIV Prevention on the Line, this update details attempts to test vaccine strategy which showed promise in the RV144 trial.
Invest in an oral PrEP-driven paradigm shift
The data all point the same way: daily oral PrEP works if you take it. This excerpt from AVAC Report: HIV Prevention on the Line, provides a number of steps to scale-up PrEP rollout.
Hormonal Contraceptives and HIV – An introductory fact sheet
This introductory 3-page document summarizes the debate over whether certain hormonal contraceptives increase women’s risk of HIV acquisition. For more basic fact sheets, visit www.avac.org/intro.
Regulatory Mapping Project
AVAC undertook this review of activities designed to strengthen regulatory capacity, particularly in Africa. This included a desk review of various planned or ongoing activities and interviews with key informants. The results are summarized by country, initiative, and objective among other parameters.
PrEP for Black Gay and Bi-sexual Men in the US: What you need to know
This factsheet includes information on accessing and paying for PrEP, side effects and outlines key information on the relevance of PrEP for Black gay and bisexual men.
When do you stop an HIV prevention trial for futility? A primer for HIV prevention advocates
This fact sheet looks at why trials are stopped early for “futility.” What does this mean, when is such a recommendation made and how does it affect other ongoing trials?